Contents

Current Medicinal Chemistry, Volume 19 - Number 20

EDITORIAL [Hot Topic: Nuclear Image-Guided Personalized Treatment and Prevention of Cancers]

, 19(20): 3253 - 3254

David J. Yang, Fanlin Kong, Lie-Hang Shen, Tomio Inoue and Saad Zakko


DOI: 10.2174/092986712801215892




Design of Peptide Imaging Agents for Whole-body and Intraoperative Molecular Imaging

, 19(20): 3255 - 3265

J. A. Moss, A. L. Vavere and A. Azhdarinia


DOI: 10.2174/092986712801215856




Positron Emission Tomography Radiopharmaceuticals for Sex Steroid Hormone Receptor Imaging

, 19(20): 3266 - 3270

Y. Kiyono, T. Mori and H. Okazawa


DOI: 10.2174/092986712801215919




Amino Acid Transporter-Targeted Radiotracers for Molecular Imaging in Oncology

, 19(20): 3271 - 3281

Fan-Lin Kong and David J. Yang


DOI: 10.2174/092986712801215946




Radiolabelled Agents for PET Imaging of Tumor Hypoxia

, 19(20): 3282 - 3289

H. Kurihara, N. Honda, Y. Kono and Y. Arai


DOI: 10.2174/092986712801215964




Bone Target Radiotracers for Palliative Therapy of Bone Metastases

, 19(20): 3290 - 3300

K. Ogawa and K. Washiyama


DOI: 10.2174/092986712801215865




Radiolabeled RGD Peptides as Integrin alpha(v)beta3–targeted PET Tracers

, 19(20): 3301 - 3309

U. Tateishi, T. Oka and T. Inoue


DOI: 10.2174/092986712801215937




Molecular Imaging Kits for Hexosamine Biosynthetic Pathway in Oncology

, 19(20): 3310 - 3314

David J. Yang, Fan-Lin Kong, Takashi Oka and Jerry L. Bryant


DOI: 10.2174/092986712801215900




Radiolabeled Nucleosides for Predicting and Monitoring the Cancer Therapeutic Efficacy of Chemodrugs

, 19(20): 3315 - 3324

C.-Y. Wu, H.-E. Wang, M.-H. Lin, L.-S. Chu and R.-S. Liu


DOI: 10.2174/092986712801215955




Hydrogen Sulphide: Biopharmacological Roles in the Cardiovascular System and Pharmaceutical Perspectives

, 19(20): 3325 - 3336

A. Martelli, L. Testai, A. Marino, M. C. Breschi, F. Da Settimo and V. Calderone


DOI: 10.2174/092986712801215928




The Role of EGFR Tyrosine Kinase Inhibitors in the First-Line Treatment of Advanced Non Small Cell Lung Cancer Patients Harboring EGFR Mutation

, 19(20): 3337 - 3352

A. Sgambato, F. Casaluce, P. Maione, A. Rossi, E. Rossi, A. Napolitano, G. Palazzolo, M. A. Bareschino, C. Schettino, P. C. Sacco, F. Ciadiello and C. Gridelli


DOI: 10.2174/092986712801215973




Designed Multiple Ligands: Basic Research vs Clinical Outcomes

, 19(20): 3353 - 3387

L. Costantino and D. Barlocco


DOI: 10.2174/092986712801215883




Emerging Anticoagulants

, 19(20): 3388 - 3416

B. Kennedy, F. S. Gargoum, L. Kennedy, F. Khan, D. R. Curran and T. M. O’Connor


DOI: 10.2174/092986712801215847




Nonanolides of Natural Origin: Structure, Synthesis, and Biological Activity

, 19(20): 3417 - 3455

P. Sun, S. Lu, T. V. Ree, K. Krohn, L. Li and W. Zhang


DOI: 10.2174/092986712801215874




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science